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University of Washington, Seattle, Washington; and jjPuget Sound Blood Center Research Institute, Seattle, WashingtonABSTRACT Using a combination of structural and mechanical characterization, we examine the effect of fibrinogen oxidation
on the formation of fibrin clots. We find that treatment with hypochlorous acid preferentially oxidizes specific methionine residues
on the a, b, and g chains of fibrinogen. Oxidation is associated with the formation of a dense network of thin fibers after activation
by thrombin. Additionally, both the linear and nonlinear mechanical properties of oxidized fibrin gels are found to be altered with
oxidation. Finally, the structural modifications induced by oxidation are associated with delayed fibrin lysis via plasminogen and
tissue plasminogen activator. Based on these results, we speculate that methionine oxidation of specific residues may be related
to hindered lateral aggregation of protofibrils in fibrin gels.INTRODUCTIONFibrinogen is a 340 kDa plasma protein and the precursor to
fibrin, which is the primary structural component of blood
clots and is critical for hemostasis after injury (1). In healthy
individuals, fibrinogen is present in the blood at concentra-
tions of 2–4 mg/mL. Upon injury, a series of biochemical
processes occur that result in the local release and activation
of thrombin. This enzyme cleaves two short peptide
sequences (fibrinopeptides A and B) from fibrinogen and
converts it to fibrin. The removal of these polypeptides
exposes binding sites and drives the self-assembly of fibrin
molecules into a half-staggered, two-stranded array termed
a protofibril. Fibrinogen has two aC domains that normally
self-associate with the central domain of the monomer.
Upon conversion to fibrin, the aC domains dissociate and
are thought to play a role in the lateral aggregation of proto-
fibrils leading to the formation of coarse fibers (2,3).
However, the extent of lateral aggregation is also affected
by solution conditions and by modifications to the fibrin-
ogen monomer (2,3).
Many disease states are associated with abnormal fibrin
clot structure. Blood clots that form in thrombotic diseases
such as ischemic stroke, diabetes, and renal impairment
tend to have thin fibrin fibers, reduced clot porosity, and
delayed fibrinolysis relative to healthy patients (4–6). How-
ever, the mechanisms underlying these structural changes
during disease remain unknown. Heterogeneous fibrin clot
formation can be the result of genetic or biochemical
modifications that may occur during protein formation or
subsequently during circulation. Known modifications to
fibrinogen include degradation of the carboxy terminal
groups of the aA and g chains, glycation of lysine residuesSubmitted August 29, 2012, and accepted for publication October 24, 2012.
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0006-3495/12/12/2399/9 $2.00in diabetes patients, and partial oxidation of methionine
residues, each of which can affect polymerization (7). By
gaining a better understanding of the impact of molecular
changes associated with disease-induced coagulopathies,
we may be able to develop medical intervention strategies
that prevent complications related to altered coagulation.
Fibrinogen is more susceptible to oxidation than most
other plasma proteins, and several coagulation factors,
including fibrinogen, are sensitive to hypochlorite oxidation
(8,9). Hypochlorous acid is generated in vivo locally at sites
of injury, infection, or inflammation as part of the natural
immune response (10). Neutrophils, a type of white blood
cell, produce high local concentrations of hypochlorous
acid in vivo through the reaction of hydrogen peroxide and
Cl via the enzyme myeloperoxidase (11). Hypochlorous
acid oxidizes methionine to form methionine sulphoxide
with a high second-order rate constant (k) of 3.8 
107 M1s1, and thus this reaction occurs preferentially
over the oxidation ofmost other amino acids (12).Methionine
oxidation by hypochlorous acid has been shown to inhibit
important regulatory coagulation proteins, including acti-
vated protein C and thrombomodulin (13,14). In such cases,
the deactivation of these proteins has been traced to the
oxidation of individual methionine residues. In fibrinogen,
oxidation with hypochlorous acid has been shown to reduce
lateral aggregation and to trigger altered lysis behavior in
fibrin clots (15). Other studies have demonstrated that re-
stricting lateral aggregation, which promotes the formation
of dense fibrous gels, is linked to delayed clot lysis due to
impaired diffusion of plasmin through smaller pores (5,16).
In this study, we examine the effect of oxidation with
hypochlorous acid on the structural, mechanical, and
lytic properties of fibrin gels. A combination of turbidity,
small-angle neutron scattering (SANS), and scanning elec-
tron microscopy (SEM) is used to characterize the structure
of the fibrin gels. Shear rheology is utilized to measure thehttp://dx.doi.org/10.1016/j.bpj.2012.10.036
2400 Weigandt et al.linear and nonlinear bulk rheological properties of fully
formed fibrin gels, and to track the dissolution of gels during
tissue plasminogen activator (tPA) and plasminogen-
induced clot lysis. The results of this work are discussed
with respect to several studies that link conformational
changes in the aC domain to inhibition of lateral aggregation
in fibrin clots.MATERIALS AND METHODS
Sample preparation
Human fibrinogen (plasminogen and von Willebrand depleted) and human-
a-thrombin were purchased from Enzyme Research Laboratories (South
Bend, IN). The fibrinogen was defrosted to 37C and dialyzed to achieve
a 99.9% exchange into a buffer solution of 0.14 M NaCl and 44 mM Hepes
titrated to pH 7.4 in deionized H2O. The fibrinogen solution was filtered
through 0.45 mm PVDF filters and the concentration was determined by
UV-Vis spectroscopy at l ¼ 280 nm with an extinction coefficient of
1.6 mg mL1cm1 (17).
The fibrinogen was oxidized with 50 or 150 mmol HOCl/g fibrinogen and
incubated for 1 h at 37C. The oxidation reaction was quenched with a 10
molar excess of L-methionine. The nonoxidized sample was made to have
the same composition as the 50 mmol sample by addition of prequenched
HOCl and methionine. After oxidation, the samples were separated into
aliquots and stored at 80C. The gels were prepared by adding CaCl2
and thrombin to activate factor XIII and convert fibrinogen to fibrin. Unless
otherwise stated, the final sample composition was 1–10 mg/mL fibrinogen,
0.16 NIH U/mL thrombin, 0.14 M NaCl, 44 mMHepes, and 2 mMCaCl2 in
deionized water at pH 7.4, and gelation was allowed to proceed for at least
1 h before characterization was performed. It should be noted that the
addition of methionine and HOCl, which were required for the oxidation
reaction, caused a negligibly small increase (<3%) in the ionic strength
of the protein solutions. However, this small increase is not expected to
significantly affect the fibrin gel morphology (18).Liquid chromatography-mass spectrometry
Methionine oxidation was analyzed by nano liquid chromatography mass
spectrometry (nanoLC-MS) (19). The fibrinogen was reduced with dithio-
threitol, alkylated with iodoacetamide, and digested with trypsin in buffer
containing 50 mM ammonium bicarbonate, 5 mM L-methionine, and 5%
acetonitrile overnight at 37C. The tryptic peptides were concentrated and
desalted with C18 extraction cartridges (3M Empore), dried under vacuum,
and then resuspended in solvent containing 0.1% formic acid, 5 mM
L-methionine, and 5% acetonitrile. The tryptic peptides from 200 ng protein
were injected for each nanoLC-MS analysis. NanoLC-MS analyses were
performed in the positive ion mode with a Thermo-Finnigan LTQ linear
ion trap mass spectrometer (San Jose, CA) coupled to a nanoAcquity
UltraPerformance LC (UPLC) system (Waters, Milford, MA). Peptides
were separated at a flow rate of 0.3 mL/min on a nanoUPLC BEH130 C18
column (100 0.075 mm, 1.7 mm;Waters) using 0.1% formic acid in water
(solvent A) and 0.1% formic acid in CH3CN (solvent B). Peptides were
eluted using a linear gradient of 5%35% solvent B over 90 min. The spray
voltage was 2.0 kV, and the temperature of the heated capillary was 200C.
The collision energy for tandem MS (MS/MS) was 35%. Methionine
oxidation was determined by the peak area from the reconstructed ion chro-
matograms of nonoxidized and oxidized methionine-containing peptides.UV-Vis
UV-Vis spectroscopymeasurementsweremade on anEvolution 300Thermo
Scientific UV-Vis spectrophotometer. Spectra over 320<l<780 nmBiophysical Journal 103(11) 2399–2407were taken in a 1 cm path-length cell once per minute for 1 h to capture
the gelation kinetics. Samples were prepared with 1 mg/mL fibrin in
0.14 M NaCl, 44 mM Hepes buffer with 0.16 NIH U/mL thrombin and
2 mM CaCl2.SEM
All SEM images were obtained on an FEI Technai (Hillsboro, OR) scanning
electron microscope with a 5 kV accelerating voltage. The samples were
prepared from 1 mg/mL fibrin gels, and gelation was allowed to proceed
for 1 h. The gel was rinsed three times with DI-H2O to extract excess
salt. The gels were frozen at 80C and lyophilized to preserve the struc-
ture. The samples were sputtered with a 5-nm-thick layer of gold with an
SPI sputter coater.Clot permeation and porosity
Clot permeation experiments were used to determine the average pore size
in the fibrin gels as previously demonstrated in the literature (20). Fibrin
gels, 8–10 mm long, containing 2.2 mg/mL 0, 50, and 150 HOCl fibrinogen
with 0.16 NIH U/mL thrombin in the NaCl-Hepes buffer were prepared in
Tygon tubing of 1/16 inch internal diameter. The gelation was allowed to
proceed for a minimum of 1 h before measurements were obtained. The
tubing with the fully formed gel was attached to a water reservoir with
a 12 cm pressure head. The water was allowed to flow through the gel
into a small scintillation vial for ~20 min, and the mass was measured to
obtain an average flow rate.Rheology
Rheology measurements were performed using a stress-controlled Anton
Paar MCR 301 rheometer (Graz, Austria) with either a cone-and-plate
configuration (25 mm diameter and 1 angle) or a concentric-cylinder
configuration (16.6 mm diameter  25 mm length and 0.71 mm gap).
The temperature was maintained at 37C with a peltier heat exchanger.
Evaporation was prevented by the application of an immiscible oil layer
on the exposed surface.
Gelation was monitored with 0.5% strain oscillations at 1 Hz for 1 h.
Frequency sweeps were performed over 0.0005<f<50 Hz at 0.5% strain.
To measure the nonlinear rheology, the shear stress (t) was gradually
increased from 0.001 Pa to the instrument’s maximum stress or until the
gel broke. During the stress ramp, the strain was measured at discrete stress
intervals that were logarithmically spaced.
Lysis experiments were monitored rheologically on the cone and plate
using 0.5% strain oscillations at 1 Hz. The samples contained 2.2 mg/mL
fibrinogen and 5 mg/mL plasminogen in standard buffer. Thrombin was
added at 1.0 NIH U/mL to initiate gelation, and 0.5 mg/mL tPA was added
to convert plasminogen to plasmin to initiate clot lysis. Both gelation and
fibrinolysis were initiated simultaneously. However, the tPA and plasmin-
ogen were added at much lower concentration to ensure that a strong gel
was formed before significant fibrinolysis occurred. Gelation and dissolu-
tion were tracked until a final plateau modulus was reached. The lysis
time was defined as the point at which the modulus was only 10% higher
than the final modulus value of the fully lysed sample.tPA activation assay
The activation of plasminogen by tPA on immobilized baseline and
oxidized (50mM HOCl) fibrinogen was assayed as described by Sauls
et al. (21). The control and oxidized fibrinogen samples were immobilized
and/or converted to fibrin with 10 nM thrombin. After immobilization,
washing, and blocking, 100 mL of a mixture of 1 nM tPA, 5 mg/mL of
plasminogen, and 0.1 mM Spectrozyme PCa (American Diagnostica)
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absorbance of the Spectrozyme cleavage product at 405 nm at room
temperature. The maximal velocity of plasmin generation was then calcu-
lated as the steepest slope of the absorbance curve. The ratios of the
maximal rates of substrate cleavage between control and oxidized fibrin-
ogen/fibrin were compared.RESULTS
Fibrinogen oxidation
Fibrinogen was oxidized by adding HOCl at physiologically
relevant concentrations between 0–150 mmol HOCl/g fibrin-
ogen (or ~0–300 mM based on 2 mg/mL fibrinogen con-
centration) (22). Circular dichroism measurements were
used to ensure that oxidation was not inducing measureable
changes in the secondary structure of the protein. The data
are reported in Fig. S1 of the Supporting Material. The
extent of oxidation for several methionine residues was
determined with nanoLC-MS and the results of this analysis
are presented in Table 1, which shows the oxidized fraction
of each selected methionine residue. In all cases, the addi-
tion of HOCl led to an increase in oxidation relative to the
native fibrinogen. Three of the analyzed methionine resi-
dues (g-78, b-367, and a-476) appear to be preferentially
oxidized (>10% oxidation in the 50 HOCl fibrinogen
and >30% oxidation in the 150 HOCl fibrinogen) over the
remaining methionine residues. In Fig. 1, the fibrinogen
crystal structure is presented with all of the methionine resi-
dues circled and the highly oxidized residues labeled
(23,24). Although the crystal structure of the aC domain
has not yet been fully characterized, the structure of the
N-terminal subdomain has been determined by a combina-
tion of circular dichroism and NMR (25). The aC domain
is included in Fig. 1 schematically with dotted lines, and
the structure of the N-terminal subdomain is highlighted
with the highly oxidized a-476 methionine labeled.Gel structure
Given the physiological importance of fibrin gels and the
existence of structure-driven coagulopathy, many studies
have sought to characterize the structure of fibrin gels
(1,17,18,23,26). Various microscopy and scattering tech-
niques have been used to examine the structure of fibrin
clots, including SEM, scanning probe microscopy, optical
microscopy, SANS, small-angle x-ray scattering, and
turbidity analysis. In this study, we characterized the struc-
ture of oxidized and untreated fibrin gels by using a combi-TABLE 1 Oxidized fraction of selected methionine residues
by HOCl with 0, 50, and 150 mM HOCl/g fibrinogen
g-78 a-91 a-476 b-190 b-305 b-367
0 HOCl 0.008 0.007 0.024 0.014 0.028 0.013
50 HOCl 0.112 0.010 0.256 0.052 0.043 0.137
150 HOCl 0.334 0.022 0.727 0.109 0.148 0.431nation of SEM, SANS, turbidity analysis, and gel
permeation. Each of these techniques has various advan-
tages and disadvantages. However, when used in combina-
tion, these techniques complement each other and provide
details about the structure of the individual fibers, the gel
porosity, and the network density.
We formed fibrin gels by adding thrombin to the prepared
fibrinogen samples at all three levels of oxidation. Calcium
(2 mM) was added to all solutions to activate Factor XIII
and promote covalent ligation. To quantify the turbidity
during gelation, we measured the absorbance at l ¼
350 nm of 1 mg/mL fibrin gels as a function of time and
plotted it in Fig. 2. We found that the gelation time was
unchanged with oxidation, which suggests that oxidation
does not affect the gelation kinetics. The turbidity of the
gels was highly influenced by oxidation, with the nonoxi-
dized fibrin forming very opaque gels and the highly
oxidized fibrin forming nearly transparent gels.
The turbidity of fibrin gels has long been linked to fiber
diameter, with fine fibers producing clear gels (17,18).
The average radius of the fibers in the 0 and 50 HOCl fibrin
gels was calculated from turbidity measurements and found
to be 89 nm and 75 nm, respectively. The 150 HOCl fibrin
gel was too transparent to accurately measure the turbidity
or determine the fiber size, but the high transparency indi-
cates the presence of much smaller fibers. Additional details
of the turbidity analysis are provided in the Supporting
Material.
To ensure that the decreasing turbidity was caused by
a reduction in fiber size, we had to demonstrate that these
changes were not attributable to inactive fibrinogen. To
that end, we added a controlled volume of buffer to the
top of a fully formed gel. After ~24 h, the fibrinogen
concentration in the tops was measured. We found that the
baseline gel contained <10% inactive fibrin. The concen-
tration of unreacted fibrin in the oxidized gels was unmea-
surable, indicating that nearly all of it was activated and
formed part of the clot.
SANS measurements were also used to quantify the
bulk average fiber diameter in the transparent 150 HOCl
fibrin gels. For SANS, a relatively high concentration
(6.5 mg/mL) of fibrinogen was used to increase the scat-
tering relative to the background. Fibrin gels from 0 and
150 HOCl fibrinogen were formed in the NaCl-Hepes buffer
in H2O. After 1 h of gelation time, the buffer was exchanged
for an identical composition buffer prepared with D2O
to minimize the incoherent background and enhance the
scattering contrast. The absolute scattering intensity (I) is
plotted against the scattering vector (q) in Fig. S4. Addi-
tional details regarding the experimental protocol, results,
and analysis of the SANS experiments are included in the
Supporting Material.
From SANS we determined that the baseline fibrinogen
had an average radius of 95 nm using a cylinder form factor
model (29). This result is consistent with the 89 nm radiusBiophysical Journal 103(11) 2399–2407
FIGURE 1 Fibrinogen molecule with all
methionine residues circled and highly oxidized
methionine residues labeled. The crystal structure
was rendered from the Protein Data Bank
(23,24). The a-C domain was added schematically
with dotted lines, including the ordered N- and
C-terminal subdomains (25).
2402 Weigandt et al.calculated from the turbidity measurement. However, we
found that the highly oxidized 150 HOCl fibrin gel was
better represented by a bimodal distribution of fiber radii
where R1 ¼ 15 nm and R2 ¼ 3.4 nm. Although the bimodal
model fit was very good, there is significant uncertainty in
the absolute value of the radii. In fact, the small radius deter-
mined from the fit is slightly less than is typically reported
for a single protofibril (~5 nm) (27). Regardless, these
results are consistent with both the SEM results reported
below and the turbidity data suggesting that very small
fibers exist in the highly oxidized gels.
Fibrin gels were also prepared from 1 mg/mL fibrinogen
for SEM analysis. In Fig. 3 SEM images at 1000 and
20,000 magnification are presented for oxidized and
untreated fibrin. Additional images at 10,000 and 50,000
are included in Fig. S2. In the 1000 magnified images, it
is clear that the network density increases dramatically
with increasing oxidation. In the nonoxidized fibrin gel,
very large fibers are separated by longer distances, giving
rise to large pores in the gel. In the 50 HOCl oxidized fibrin
gel, the fiber and pore sizes are reduced relative to the
nonoxidized gel, but the most dramatic difference is
observed in the 150 HOCl fibrin gel. This gel primarily con-
tained densely packed but very small fibers. It should beFIGURE 2 Absorbance at 350 nm for 1 mg/mL fibrin gels plotted as
a function of time during gelation.
Biophysical Journal 103(11) 2399–2407noted that in the 150 HOCl oxidized fibrin gels, the fibers
were so closely packed in the bulk of gel that the sputtered
gold obscured the individual fibers. For this reason, these
images were taken near the edge of the gel where the
fiber density was much lower. It is expected that the high
fiber density and reduced porosity observed in the oxidized
fibrin gels would lead to reduced diffusivity through
the gel and impede the transport of enzymes critical for
fibrinolysis.
The pore size in 2.2 mg/mL gels was quantified with a gel
permeation study similar to the one described by Carr and
Hardin (20). Darcy’s constant (Da), which is related to the
gel porosity, is defined by Eq. 1:
Da ¼ Vhh
AtP
(1)
where V is the volume of water that passes through the gel in
time (t), h is the viscosity of water, h is the length of the
fibrin clot plug, A is the cross-sectional area of the tube,
and P is the water pressure head. The average pore size
(RP) can be obtained from a relation derived by Carr and
Hardin (20):
RP ¼ 0:5093
Da
1 =
2
(2)
The results of this study indicate that there is a decrease in
the pore size with increasing oxidation. The 0, 50, and 150
HOCl fibrin gels have average pore radii of 540, 370,
and 230 nm, respectively, based on the gel permeation
measurements.Rheology
The multiscale structure of fibrin gels gives rise to inter-
esting linear and nonlinear mechanical properties that are
critical for the function of fibrin clots in vivo. Altered
mechanical properties reflect changes in clot structure, and
measurements of these properties are often used as a diag-
nostic tool for coagulopathy. Typically the mechanical
properties of fibrin gels are measured by means of shear
rheology (in research) or thromboelastography (in clinical
applications) (2,30). In shear rheology, the structure of
FIGURE 3 SEM images of fibrin gels from
HOCl oxidized fibrinogen at 1000 (top) and
20,000 (bottom) magnification.
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nonlinear elastic modulus as a function of concentration
or strain (31–33). Given the vast number of physiological
modifications that human fibrinogen can undergo, mechan-
ical measurements are a powerful tool for detecting
abnormal fibrin coagulation.
In this study, we measured the mechanical properties of
the fibrin gels using shear rheology techniques. At low strain
(<1%), the fibrin gels were below the linear viscoelastic
limit. Small-amplitude oscillations at strains within the
linear viscoelastic limit were used to track the evolving
elastic (G0) and viscous (G00) moduli during gelation. The
viscous and elastic moduli are plotted as a function of
time in Fig. 4. As with the UV-Vis measurements, we foundFIGURE 4 Elastic (G0) and viscous (G00) moduli of oxidized and baseline
fibrin gels plotted as a function of time during gelation.no significant changes in the gelation time, and in all three
cases the modulus had increased only slightly at the end
of the 1 h gelation period. A frequency sweep between
0.0005 and 50 Hz was also performed and data from these
measurements are reported in Fig. S6. All of the samples,
oxidized and baseline, have gel-like properties, with
G0 > G00 over the entire frequency range that was probed.
This is typical for cross-linked fibrin at the concentrations
probed in this study.
In Fig. 5, we examine the concentration dependence of
the linear elastic modulus. The elastic modulus at 0.5%
strain is plotted over a concentration range spanning two
decades. We find that the oxidized gels are systematically
weaker than the baseline gels, but the overall concentration
dependence is effectively the same. The linear elastic
modulus is found to vary exponentially with fibrinogen
concentration such that G0 increases as C2.12, C2.32, and
C2.35 for the 0, 50, and 150 HOCl fibrin gels, respectively.
The variation in the exponential dependence is thought to
be a result of experimental error rather than an indication
of any underlying structural changes.
MacKintosh et al. (31) proposed a model that predicts that
the linear elastic modulus of entangled biopolymer
networks should have an exponential concentration depen-
dence with G0~C2.2. Various experimental studies have
reported an exponential dependence for cross-linked fibrin
ranging between G0~C1.66 and G0~C2.3 (2,26,31,34). The
values reported herein are consistent with those results.
Additionally, we used SDS-PAGE to demonstrate that cova-
lent cross-linkage by Factor XIIIa is not inhibited by HOCl
oxidation. A scan of the gel is presented in Fig. S5. The 115
kD g-g dimers (g2) are prominent in both the oxidized and
native fibrin samples and are indicative of covalent cross-
linkage via Factor XIIIa. This is clear evidence that FactorBiophysical Journal 103(11) 2399–2407
FIGURE 5 Linear elastic modulus of the fibrin gels plotted against the
fibrinogen concentration.
FIGURE 6 Instantaneous modulus (GInst) of fibrin gels with various
concentrations of fibrinogen and oxidized to different levels with 0, 50,
and 150 mmol HOCl/g fibrinogen. The data plotted are the average of at
least three trials, with error bars corresponding to the standard deviation.
2404 Weigandt et al.XIII activation by thrombin and the activity of Factor XIIIa
are not impaired by HOCl oxidation.
Fibrin gels are also known to exhibit highly nonlinear
strain-hardening mechanical properties. To measure the
nonlinear rheology of the oxidized fibrin gels, we applied
a continuously increasing stress ramp until the gel failed,
and measured the resulting strain at discrete stress intervals.
It should be noted, however, that all of the 6.5 mg/mL fibrin
gels and some of the 4.3 mg/mL fibrin gels were too strong
to break in the rheometer. We determined the instantaneous
modulus (GInst) by taking the derivative of the shear stress
(t) with respect shear strain (g):
GInst ¼ dt
dg
(3)
Curves of the average instantaneous modulus for 1.1, 2.2,
4.3, and 6.5 mg/mL fibrin gels formed from baseline and
oxidized fibrinogen are plotted in Fig. 6. The error bars
reflect the standard deviation from a minimum of three
different gels.
The nonlinear rheology of fibrin is related to the under-
lying hierarchical structure of the clot and therefore is
affected by alterations to the monomer. Like many biopoly-
mers, fibrin gels are highly extensible and exhibit strain
hardening (32,33,35). In this study, all of the fibrin gels
we tested strain hardened regardless of concentration
or oxidation levels. The instantaneous modulus at the
maximum strain before gel failure was typically 1–2 orders
of magnitude greater than the linear elastic modulus. We
consistently found that the maximum strain and maximum
modulus were lower for oxidized gels than for baseline
gels. For the 1 mg/mL gels, the average maximum strain
before failure was 202 5 31, 143 5 10, and 157 5 20%
for 0, 50, and 150 HOCl gels, respectively. The averageBiophysical Journal 103(11) 2399–2407maximum modulus reached before gel failure was
30005 1500, 14005 100, and 8005 200 Pa, respectively.
Although the linear elastic moduli and maximum instanta-
neous moduli of the oxidized gels were lower than those
measured in the baseline gels, at intermediate strains
(approaching 100%), the magnitude of the instantaneous
modulus of the baseline and oxidized gels began to equalize.
All of the baseline gels experienced a second increase in the
magnitude of strain hardening at very high strain. This
upturn also occurred in the higher-concentration 50 HOCl
gels and the 6.5 mg/mL 150 HOCl gel.
The limit of linear viscoelasticity of the gels was also
affected by HOCl oxidation. We found that the onset of
strain hardening occurred at progressively higher strain
with increasing oxidation. We quantified the delayed strain
hardening by measuring the strain at which the instanta-
neous modulus reached 200% of the linear modulus. This
characteristic strain was found to be 3.6 5 0.6, 5.5 5
1.5, and 7.5 5 1.1% for 0, 50, and 150 HOCl fibrin gels,
respectively, when averaged over all concentrations. The
linear viscoelastic limit also increased slightly with concen-
tration, which is consistent with current models for strain
hardening (33,36).Clot lysis
HOCl oxidation has been implicated in altered fibrinolysis
in at least one previous report (15). Given the altered clot
structure and rheology observed in this study, we expected
FIGURE 7 Fibrinolysis induced by tPA and plasminogen in 2.2 mg/mL
fibrin gels formed from fibrinogen treated with 0, 50, and 150 mmol/g
fibrinogen as monitored by small-amplitude oscillatory rheology. The lysis
time for these specific gels is marked with an arrow. The reported lysis
times represent the average of three trials.
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a result of reduced diffusivity of enzymes and cofactors
through smaller pores. From the gel permeation experi-
ments, we measured the pore size of the gels to be
540 nm for untreated fibrinogen, 370 nm for the 50 HOCl
oxidized fibrinogen, and 231 nm for the 150 HOCl oxidized
fibrinogen in 2.2 mg/mL fibrin gels. The Stokes radius of
plasminogen is ~5 nm (37). The diffusion coefficient for
plasminogen at infinite dilution in water (DAB) can be calcu-
lated from the Stokes-Einstein equation:
DAB ¼ kT
6pRmB
(4)
where k is the Boltzmann’s coefficient, T is the temperature,
R is the radius of plasminogen, and mB is the viscosity of
water (DAB ¼ 6.49  1011 m2s1 at 37C).
In the case of plasminogen diffusing through a fibrin gel,
the added restriction to diffusion imposed by the fiber
network must be considered. Two correction factors, the
steric partition coefficient (F1(4)) and the hydrodynamic
hindrance factor (F2(4)), are used to account for this effect,
such that an effective diffusion coefficient for plasminogen
through the fibrin gel (DAF) can be calculated with the
following equation (38):
DAF ¼ DABF1ð4ÞF2ð4Þ (5)
Both of these parameters are functions of the reduced pore
diameter (4):
4 ¼ dplasminogen
dpore
(6)
where dplasminogen is the diameter of the plasminogen
protein, and dpore is the estimated pore diameter. The steric
partition coefficient accounts for the volume occupied by
the plasminogen because it cannot be located closer than
one radius away from the pore wall. This factor was origi-
nally derived using geometric arguments and is defined in
Eq. 7 (38):
F1ð4Þ ¼ ð1 4Þ2 (7)
The hydrodynamic hindrance factor accounts for the
hindered Brownian motion of plasmin within the pore
volume. The hydrodynamic hindrance factor developed
by Renkin (39) for hard spheres diffusing through cylin-
drical pores is valid for 0 < 4 < 0.6. Although the pores
in the fibrin gels are not cylindrical and the plasminogen
is not a hard sphere, Eq. 8 still remains a reasonable appro-
ximation for the hydrodynamic hindrance factor in this
system:
F2ð4Þ ¼ 1 2:1044þ 2:0943  0:9545 (8)Given the calculated pore sizes for fibrin gels with and
without oxidation, the effective diffusion coefficients of
plasminogen in gels are found to be 5.8  1011, 5.5 
1011, and 4.9  1011 m2s1 for the 0, 50, and 150
HOCl gels, respectively. Based on these calculated diffusion
coefficients, we expect that the lysis time for oxidized
fibrin gels will be affected by reduced porosity in the
oxidized gels.
We performed a series of fibrinolysis experiments using
the rheometer with small-amplitude shear oscillations to
monitor the elastic and viscous moduli during gelation,
and the subsequent lysis of fibrin gels in situ. In this exper-
iment, 2.2 mg/mL fibrinogen and 1 mg/mL plasminogen
were combined with 1 NIH U/mL thrombin and
0.5 mg/mL tPA, and loaded directly into the rheometer using
the cone-and-plate geometry. We determined the lysis time
by taking the time at which the elastic modulus reached
a value that was just 10% larger than the final plateau elastic
modulus. The results of this experiment are presented in
Fig. 7, with the lysis time of the representative data sets indi-
cated by arrows. We found that, as expected, the lysis time
was delayed in oxidized gels.
Fibrin is known to increase the rate of tPA-induced
conversion of plasminogen to plasmin by increasing expo-
sure of tPA-binding sites (40). In a comparison of fibrinogen
with fibrin, tPA-induced plasmin activation is typically
increased by a ratio of ~1:1.5–2. We also anticipated
that fibrinogen oxidation could decrease the rate of tPA-
dependent plasminogen activation. However, both control
and oxidized fibrin/fibrinogen plasminogen activation ratios
were similar (1.60 vs. 1.66, respectively), leading us to con-
clude that the rate of tPA-induced activation of plasminogenBiophysical Journal 103(11) 2399–2407
2406 Weigandt et al.is essentially unchanged by the presence of oxidized fibrin.
Therefore, the delayed lysis time is likely to be primarily
attributed to changes in clot architecture and diffusion.DISCUSSION AND CONCLUSIONS
Fibrinogen treatment with HOCl leads to the preferential
oxidation of specific methionine residues on the a, b,
and g chains. The oxidation of one or all of these residues
is associated with reduced lateral aggregation of protofibrils
resulting in gels with smaller fibers and higher fiber density
compared with untreated fibrin gels. Both the linear and
nonlinear mechanical properties are affected by oxidation.
Oxidized fibrin gels are weaker and experience a delayed
onset of strain hardening.
High fiber density as a result of fine fiber formation is
thought to reduce the diffusion rate of plasminogen through
the gel and lead to prolonged lysis times. Several medical
conditions associated with thrombosis, including diabetes
and impaired kidney function, have been associated with
these characteristics (7,8). The results presented in this
study suggest that oxidation related to neutrophil activation
and inflammation may be associated with these diseases
(10,11). Moreover, in this work we demonstrate that the
delayed lysis observed in these oxidized gels is not a result
of decreased tPA-dependent activation of plasminogen, but
rather may be explained by a reduction in gel porosity and
hindered diffusion of the plasminogen through the clot.
These results support an oxidative modification of fibrin
polymerization, as previously reported (41). Although the
exact mechanism of altered fibrin polymerization remains
unclear, several studies have demonstrated inhibited lateral
aggregation of protofibrils through the manipulation of the
a-C domains (42–45). Removal of the a-C domain or substi-
tution with chicken a-C domains inhibits lateral aggregation
and results in clots similar to ours with higher fiber density,
weaker gels, and prolonged fibrinolysis times (43,44). The
distinct similarities between the abnormal coagulation
observed with the a-C domain variants and our results sug-
gest that perhaps oxidation via HOCl acts by promoting a
conformational change in the a-C domain that inhibits
interactions with adjacent domains during fibrin fiber
polymerization.
The most preferentially oxidized methionine residue
is a-476, with 2.4%, 25.6%, and 72.7% oxidized in the
0, 50, and 150 HOCl solutions, respectively. This methio-
nine is the first residue on a second b-sheet hairpin complex
in the N-terminal subdomain of the a-C domain. Tsurupa
and colleagues (25) found that this second b-sheet hairpin
is relatively unstable in human fibrinogen and that the
unfolding of this structure reduces the extent of a-C frag-
ment oligomerization. Although we present no conclu-
sive evidence demonstrating that conformational changes
in the a-C domain lead to the impaired lateral aggregation
of protofibrils in oxidized fibrin gels, our results in conjunc-Biophysical Journal 103(11) 2399–2407tion with recent literature do suggest that oxidation of the
methionine residue a-476 could be, at least in part, respon-
sible for the altered clotting of HOCl oxidized fibrin gels.
This work highlights the need for further studies of the
effect of specific residue oxidation on the conformation
and oligomerization of the a-C domain.SUPPORTING MATERIAL
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